Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (10) , 1357-1363
- https://doi.org/10.1097/00002030-200007070-00008
Abstract
To evaluate the relationship between the HIV viral burden in individuals prior to receiving highly-active antiretroviral therapy (HAART) and the viral burden after withdrawal of HAART. Retrospective cohort study at the National Institutes of Health, Bethesda, Maryland, USA. Fourteen HIV-infected patients who achieved and maintained viral control on HAART who subsequently discontinued HAART. Pre- and post-HAART viral loads measured from plasma or serum. Patients achieved viral control (10 After discontinuing HAART, individuals had rebounds in their viral burdens approximating pre-HAART levels, even after a significant lapse of time approaching 5 years. Our data suggest that an intrinsic viral load set-point may exist, and that a single interruption of an effective regimen with viral suppression for almost 2 years does not significantly alter this set-point.Keywords
This publication has 29 references indexed in Scilit:
- The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurementsAIDS, 1999
- Discontinuation of Anticytomegalovirus Therapy in Patients With HIV Infection and Cytomegalovirus RetinitisJAMA, 1999
- Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral TherapyJAMA, 1999
- Longitudinal Human Immunodeficiency Virus Type 1 Load in the Italian Seroconversion Study: Correlates and Temporal Trends of Virus LoadThe Journal of Infectious Diseases, 1999
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral TherapyNew England Journal of Medicine, 1999
- HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatmentAIDS, 1999
- Characterization of HIV-1-specific T-helper cells in acute and chronic infectionImmunology Letters, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary StudyNew England Journal of Medicine, 1995